Medprin Regenerative Medical Technologies Co.,Ltd.’s Net Profit Rose 9.3% in First Quarter of 2023

Medprin Regenerative Medical Technologies Co.,Ltd. (广州迈普再生医学科技股份有限公司) (301033.SZ) reported a net profit of 7.8 million yuan in the first quarter of 2023, up 9.3% year-on-year.

Meanwhile, the company posted 44.5 million yuan in revenue, up 19.4% year-on-year.

At the end of the reporting period, it had 728.4 million yuan in total assets and 118 million yuan in total liabilities, with a liability-to-asset ratio of 16.2%.